Publikationen in Zusammenarbeit mit Forschern von Karolinska Institute (5)

2019

  1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 121-130

  2. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 131-138

  3. Neurological disorders in central Spain, second survey: Feasibility pilot observational study

    Journal of Medical Internet Research, Vol. 21, Núm. 1

2017

  1. Rivaroxaban with or without aspirin in stable cardiovascular disease

    New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330

2013

  1. Leg fat might be more protective than arm fat in relation to lipid profile

    European Journal of Nutrition, Vol. 52, Núm. 2, pp. 489-495